Accolade Inc (STU:4NE1)
€ 3.42 0.12 (3.64%) Market Cap: 275.12 Mil Enterprise Value: 279.28 Mil PE Ratio: 0 PB Ratio: 0.70 GF Score: 61/100

Q1 2024 Accolade Inc Earnings Call Transcript

Jun 29, 2023 / 08:30PM GMT
Release Date Price: €11.5 (+4.55%)
Operator

Good day, and thank you for standing by, and welcome to Accolade First Quarter '24 Earnings Results Conference Call. (Operator Instructions).

Todd Friedman
Accolade, Inc. - SVP of IR

Thanks, operator. Welcome, everyone, to our fiscal first quarter earnings call. With me on the call today are our Chief Executive Officer, Rajeev Singh; and our Chief Financial Officer, Steve Barnes. Shantanu Nundy, our Chief Health Officer, will join for the question-and-answer portion of the call later. Before turning the call over to Rajeev, please note that we'll be discussing certain non-GAAP financial measures that we believe are important when evaluating Accolade's performance over. It's over to our CEO, Rajeev Singh.

Rajeev Singh
Accolade, Inc. - Chairman of the Board & CEO

Thank you, Todd, and thank you, everyone, for joining us today. We entered fiscal Q2 with optimism regarding our company, our category and our opportunity to build a nationwide customer-obsessed health care delivery system off the foundation of advocacy

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot